Reference : In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat with...
Scientific congresses and symposiums : Poster
Human health sciences : Radiology, nuclear medicine & imaging
http://hdl.handle.net/2268/215026
In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat with AAV-induced overexpression of alpha-synuclein: a [18F]FMT microPET study.
English
Becker, Guillaume mailto [Université de Liège - ULiege > > Centre de recherches du cyclotron >]
Bahri, Mohamed Ali mailto [Université de Liège - ULiege > > Centre de recherches du cyclotron >]
Michel, Anne [UCB Pharma > > > >]
Hustadt, F [UCB Pharma > > > >]
Luxen, André mailto [Université de Liège - ULiege > Département de chimie (sciences) > Laboratoire de chimie organique de synthèse >]
Garraux, Gaëtan mailto [Université de Liège - ULiege > Département des sciences biomédicales et précliniques > Biochimie et physiologie du système nerveux >]
Lemaire, Christian mailto [Université de Liège - ULiege > > Centre de recherches du cyclotron >]
Plenevaux, Alain mailto [Université de Liège - ULiege > Département de chimie (sciences) > Département de chimie (sciences) >]
8-Mar-2016
A0
Yes
International
European Molecular Imaging Meeting - EMIM 2016
8 mars 2016 au 10 marx 2016
European Society for Molecular Imaging
Utrecht
Netherland
[en] microPET ; Imaging ; preclinical ; Parkinson ; AAV ; synuclein ; FMT ; fluorine 18 ; dopamine
[en] Objectives: Rat models of Parkinson’s disease (PD), such as progressive neurodegeneration induced by adeno-associated virus (AAV)-mediated over-expression of human -synuclein (A53T) in midbrain dopamine neurons, are useful to evaluate novel antiparkinsonian therapies [1]. In vivo quantitative imaging of dopamine neurotransmission allows longitudinal evaluation of such PD’s rat model [2]. In this study, we investigate DA presynaptic function, with [18F]FMT PET (radiotracer of the L-aromatic amino acid decarboxylase enzyme), in the AAV A53T PD’s rat model, and correlate the results with behavioral measurements.

Methods: All animals were injected with 2 µL A53T -synuclein (n=6) or GFP (n=2) AAV2/9 in the right substantia nigra. Striatal DA presynaptic activity was assessed by dynamic PET with [18F]FMT [3] at 18 weeks post-lesion. Kinetic analysis was performed by “Patlak Reference” model, using PMOD software. Rats were monitored for motor behavior and assessed before the lesion, and at 4, 12 and 18 weeks post-lesion.

Results: As consequence of AAV-mediated A53T overexpression, significant decrease of [18F]FMT accumulation was recorded in the striatum ipsilateral to the lesion. Lesioned rats had dramatically reduced uptake constant Ki in the ipsilateral striatum compared to the contralateral striatum (p<0.001 for [18F]FMT) and to the ipsilateral striatum of sham-treated rats (p<0.001). Significant deficit in stepping adjustment was observed with the contralateral forepaw at 4, 12 and 18 weeks. Significant reduction of the time spent on the rotarod was also measured at 12 and 18 weeks.

Conclusions: Our results report good correlations between [18F]FMT PET outcomes and behavioral results. The sensitivity of the data quantification obtained in this study, confirms the interest to pursue longitudinal investigations with [18F]FMT to monitor dopaminergic dysfunction in this progressive preclinical model of PD.
Centre de Recherches du Cyclotron - CRC
Fonds de la Recherche Scientifique (Communauté française de Belgique) - F.R.S.-FNRS
Researchers ; Professionals ; Students
http://hdl.handle.net/2268/215026

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
FMT_Poster_EMIM_2016.pdfAuthor preprint713.46 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.